Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?


Journal

The Journal of laryngology and otology
ISSN: 1748-5460
Titre abrégé: J Laryngol Otol
Pays: England
ID NLM: 8706896

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 30 6 2021
medline: 10 8 2021
entrez: 29 6 2021
Statut: ppublish

Résumé

To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio within 10 days of the clinical onset of coronavirus disease 2019 and 60 days after. Seventy-seven patients were included in this study. D-dimer, procalcitonin, ferritin and neutrophil-to-lymphocyte ratio correlated significantly with severe coronavirus disease 2019. No significant correlations were found between baseline and 60-day Connecticut Chemosensory Clinical Research Center test scores and the inflammatory markers assessed. Olfactory disturbances appear to have little prognostic value in predicting the severity of coronavirus disease 2019 compared to D-dimer, ferritin, procalcitonin and neutrophil-to-lymphocyte ratio. The lack of correlation between the severity and duration of olfactory disturbances and serum levels of inflammatory markers seems to further suggest that the pathogenetic mechanisms underlying the loss of smell in coronavirus disease 2019 patients are related to local rather than systemic inflammatory factors.

Identifiants

pubmed: 34184623
doi: 10.1017/S0022215121001651
pii: S0022215121001651
pmc: PMC8267245
doi:

Substances chimiques

Biomarkers 0
Fibrin Fibrinogen Degradation Products 0
Procalcitonin 0
fibrin fragment D 0
C-Reactive Protein 9007-41-4
Ferritins 9007-73-2
L-Lactate Dehydrogenase EC 1.1.1.27

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

723-728

Auteurs

L A Vaira (LA)

Maxillofacial Surgery Operative Unit, University Hospital of Sassari, Sassari, Italy.
Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy.

A De Vito (A)

Infectious and Tropical Diseases Unit, University Hospital of Sassari, Sassari, Italy.

G Deiana (G)

Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy.
Clinical Epidemiology and Medical Statistics Unit, University Hospital of Sassari, Sassari, Italy.

C Pes (C)

Internal Medicine Department, University Hospital of Sassari, Sassari, Italy.
Neuro-COVID Department, University Hospital of Sassari, Sassari, Italy.

F Giovanditto (F)

Maxillofacial Surgery Operative Unit, University Hospital of Sassari, Sassari, Italy.
Onco-COVID Department, University Hospital of Sassari, Sassari, Italy.

V Fiore (V)

Infectious and Tropical Diseases Unit, University Hospital of Sassari, Sassari, Italy.

J R Lechien (JR)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federation of Oto-rhino-laryngological Societies ('YO-IFOS'), Paris, France.
Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

S Saussez (S)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federation of Oto-rhino-laryngological Societies ('YO-IFOS'), Paris, France.
Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

D Policicchio (D)

Neurosurgery Operative Unit, University Hospital of Sassari, Sassari, Italy.

R Boccaletti (R)

Neurosurgery Operative Unit, University Hospital of Sassari, Sassari, Italy.

G Madeddu (G)

Infectious and Tropical Diseases Unit, University Hospital of Sassari, Sassari, Italy.

S Babudieri (S)

Infectious and Tropical Diseases Unit, University Hospital of Sassari, Sassari, Italy.

A Pazzola (A)

Onco-COVID Department, University Hospital of Sassari, Sassari, Italy.

F Bandiera (F)

Internal Medicine Department, University Hospital of Sassari, Sassari, Italy.
Neuro-COVID Department, University Hospital of Sassari, Sassari, Italy.

A G Fois (AG)

Respiratory Diseases Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

A F Piana (AF)

Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy.
Clinical Epidemiology and Medical Statistics Unit, University Hospital of Sassari, Sassari, Italy.

C Hopkins (C)

King's College, London, UK.

G De Riu (G)

Maxillofacial Surgery Operative Unit, University Hospital of Sassari, Sassari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH